Clinical Trials
24 trialsStudy of CAR-T Therapy in Older Patients
Memorial Sloan Kettering Cancer Center
CART I5M
Poitiers University Hospital
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Wake Forest University Health Sciences
MCSF-MYELOME
Centre Hospitalier Universitaire, Amiens
AMBROBiMM
Assistance Publique - Hôpitaux de Paris
ProApix
Centre Hospitalier Universitaire de Saint Etienne
VESICOM
Centre Hospitalier Universitaire de Saint Etienne
SANGUINE
JaxBio Ltd
64Cu-LLP2A for Imaging Multiple Myeloma
Washington University School of Medicine
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
MYELOME-MM
Assistance Publique Hopitaux De Marseille
PET Imaging of Subjects Using 124I-PU-AD
Samus Therapeutics, Inc.
IMMUNO-MYELO
Rennes University Hospital
MMRD
Hospices Civils de Lyon
Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma
Washington University School of Medicine
MUM
Universitair Ziekenhuis Brussel
MRD
Boston Medical Center
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
Memorial Sloan Kettering Cancer Center
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
Ohio State University Comprehensive Cancer Center
Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro
Dana-Farber Cancer Institute
METRO B
Centre Hospitalier Universitaire de Saint Etienne
MM-FISH/DNA
Rigshospitalet, Denmark
PACMoG
Rennes University Hospital